Vision Disorders, Stress, Psychological, Psychopathy, Self Efficacy
Conditions
Keywords
Vision Disorders; Stress, Psychological
Brief summary
The aim of this study is to evaluate the efficacy of cognitive - behavioral therapy for the control of psychopathological stress and the disease of people with Retinitis Pigmentosa (RP).
Detailed description
This randomized controlled trial aims to evaluate the efficacy of cognitive - behavioral therapy for the control of psychopathological stress and the disease of people with Retinitis Pigmentosa (RP) on aspects such as vulnerability to stress, perceived stress, psychopathological state, general self-efficacy, resilience, satisfaction with social support and visual field. This study has two groups: 1) cognitive - behavioral therapy group, and 2) Standard intervention or control group. The two interventions will be conducted for 3 months (with a total of 12 sessions), one session per week, with a duration of 90 minutes per session.
Interventions
BEHAVIORALA cognitive-behavioral intervention program
In this program, participants receive a training of assertive skills, social skills, acceptance, among other psychological aspects.
Participants receive different activities conducted by a psychologist in the association where the attend.
Sponsors
Universidad de Granada
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* diagnosed with Retinitis Pigmentosa (legally blind RP patients). * meet the membership criteria of the Spanish National Association of ONCE. * having a reduction of the visual field of at least 10 degrees in both eyes * having an age between 18 and 65 years.
Exclusion criteria
* no visual remainders (advanced retinosis). * no studies. * cognitive impairment, determined by the Spanish Mini-Mental State Examination - MMSE test. * mobility problems * high risk of falls associated with retinosis, measured by the Morse scale, with a score over 50 points.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change from Baseline in vulnerability to stress at 12 weeks | Twelve weeks | This scale registeres the aspects that influence the ability to deal with stress |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change from Baseline in Symptom Checklist-90-Revised Questionnaire at 12 weeks | Twelve weeks | This instrument is a 90-item self-report symptom inventory developed by Leonard R. Derogatis in the mid-1970s to measure psychological symptoms and psychological distress. |
| Change from Baseline in General Self efficacy scale at 12 weeks | Twelve weeks | This scale assesses people's stable believe about their ability to appropriately manage a wide kind of life stressors |
| Change from Baseline in Perceived stress scale at 12 weeks | Twelve weeks | This scale evaluates the degree to which situations in one's life are appraised as stressful |
| Change from Baseline in Social support questionnaire at 12 weeks | Twelve weeks | This instrument evaluates perceived Social support. |
| Change from Baseline in Visual Field Test at 12 weeks | Twelve weeks | This method evaluates the visual field of two eyes |
| Change from Baseline in Connor-Davidson Resilience Scale at 12 weeks | Twelve weeks | This scale evaluates stress coping ability. |
Countries
Spain
Outcome results
None listed